| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/14/2013 | US20130065940 Double-stranded rna molecules with stability in mammalian body fluid, preparation and application thereof |
| 03/14/2013 | US20130065939 Compositions and methods for silencing genes expressed in cancer |
| 03/14/2013 | US20130065938 Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer |
| 03/14/2013 | US20130065897 Compounds, preparation and uses thereof |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130065837 Integrin interaction inhibitors for the treatment of cancer |
| 03/14/2013 | US20130065836 Biomarker for gastric cancer |
| 03/14/2013 | US20130065835 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof |
| 03/14/2013 | US20130065834 Modulators of proteasome activity |
| 03/14/2013 | US20130065830 Dopamine Neuron Stimulating Peptide-11 Protection From Complex 1 Mitochondrial Inhibitors |
| 03/14/2013 | US20130065825 Compositions and Methods for Delaying Senescence or Cell Death in Neurons |
| 03/14/2013 | US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv |
| 03/14/2013 | US20130065814 Inductive production of pluripotent stem cells using synthetic transcription factors |
| 03/14/2013 | US20130065792 Inducible expression of sglt5, methods and kits using the same |
| 03/14/2013 | US20130065310 Use of endogenous promoters to express heterologous proteins |
| 03/14/2013 | US20130065307 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 03/14/2013 | US20130065306 Method for maturing and synchronizing conifer somatic embryos |
| 03/14/2013 | US20130065305 Mammary artery derived cells and methods of use in tissue repair and regeneration |
| 03/14/2013 | US20130065304 Differentiation process of mesenchymal stem cells and therapeutic use thereof |
| 03/14/2013 | US20130065303 Method for inducing spheroid formation of adipose-derived stem cells and trans-differentiation into neural lineage |
| 03/14/2013 | US20130065302 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 03/14/2013 | US20130065301 Systems and methods for cryopreservation of cells |
| 03/14/2013 | US20130065300 Dry powder cells and cell culture reagents and methods of production thereof |
| 03/14/2013 | US20130065299 Actriib-fc polynucleotides, polypeptides, and compositions |
| 03/14/2013 | US20130065298 siRNA-MEDIATED GENE SILENCING |
| 03/14/2013 | US20130065295 Compositions and Methods Relating to Proteins Requiring Gamma-Carboxylation |
| 03/14/2013 | US20130065276 Compositions and methods of treating disease with fgfr fusion proteins |
| 03/14/2013 | US20130065275 Serum-free mammalian cell culture medium, and uses thereof |
| 03/14/2013 | US20130065243 Method for producing induced pluripotent stem cells |
| 03/14/2013 | US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 03/14/2013 | US20130065227 Methods of increasing macropinocytosis in cancer cells |
| 03/14/2013 | US20130064960 Cucumber variety nun 55506 cup |
| 03/14/2013 | US20130064959 New melon variety nun 02602 me |
| 03/14/2013 | US20130064859 Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease |
| 03/14/2013 | US20130064853 Parasite vaccine |
| 03/14/2013 | US20130064851 Inactivated staphylococcal whole-cell vaccine |
| 03/14/2013 | US20130064844 Non-splicing variants of gp350/220 |
| 03/14/2013 | US20130064840 Hjurp peptides and vaccines including the same |
| 03/14/2013 | US20130064838 Enhanced death receptor agonists |
| 03/14/2013 | US20130064837 Integrin alpha-v beta8 neutralizing antibody |
| 03/14/2013 | US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 03/14/2013 | US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 03/14/2013 | US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof |
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064810 Methods and Compositions for the Detection and Treatment of Cancer involving miRNAs and miRNA Inhibitors and Targets |
| 03/14/2013 | US20130064805 Highly functional enzyme having alpha-galactosidase activity |
| 03/14/2013 | US20130064802 Methods, compositions, and assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease |
| 03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
| 03/14/2013 | US20130064800 Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
| 03/14/2013 | US20130064799 Methods for promoting cell reprogramming |
| 03/14/2013 | US20130064798 Methods and compositions for treating congestive heart failure |
| 03/14/2013 | US20130064797 Composition for mucosally delivering fruit cell cultures and/or preparations derived therefrom and methods of using same |
| 03/14/2013 | US20130064795 Immune modulation |
| 03/14/2013 | US20130064791 Interferon Analogs |
| 03/14/2013 | US20130064788 Il-17 family cytokine compositions and uses |
| 03/14/2013 | US20130064787 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 03/14/2013 | US20130064786 siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME |
| 03/14/2013 | US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | DE102011112955A1 Verfahren zur Herstellung eines biologischen Gewebekonstrukts und Verwendung spezifisch gewonnener autologer Zellen A method for preparing a biological tissue construct and use of specific autologous cells obtained |
| 03/14/2013 | CA2848222A1 Crystalline diacylhydrazine and the use thereof |
| 03/14/2013 | CA2847715A1 Plants having enhanced nitrogen efficiency |
| 03/14/2013 | CA2847623A1 Mutant endoglucanase |
| 03/14/2013 | CA2847575A1 Method for increasing osteoblastic function |
| 03/14/2013 | CA2846511A1 Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
| 03/13/2013 | EP2568039A1 Thermophilic micro-organisms for ethanol production |
| 03/13/2013 | EP2567982A1 Antibody against carcinoembryonic antigen and uses thereof |
| 03/13/2013 | EP2567976A2 Antibodies against CD38 for treatment of multiple myeloma |
| 03/13/2013 | EP2567971A2 Peptide vaccines comprising Seq Id 80, 100 or 101 for cancers expressing tumor-associated antigens |
| 03/13/2013 | EP2567968A1 Polypeptides targeting glycosylated Muc2 proteins, methods of synthesis, their nucleic acids and uses therof |
| 03/13/2013 | EP2566975A2 Screening methods, compositions identified thereby, tools useful for the identification thereof, and cell populations produced thereby |
| 03/13/2013 | EP2566972A1 Compositions for linking zinc finger modules |
| 03/13/2013 | EP2566968A1 Plants having increased tolerance to herbicides |
| 03/13/2013 | EP2566955A2 Stem cell bank for personalized medicine |
| 03/13/2013 | EP2566954A1 Immunotherapy using redirected allogeneic cells |
| 03/13/2013 | EP2566951A1 Method of reseeding adherent cells grown in a hollow fiber bioreactor system |
| 03/13/2013 | EP2566945A1 Automated filling of flexible cryogenic storage bags with therapeutic cells |
| 03/13/2013 | EP2566566A1 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 03/13/2013 | EP2566495A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| 03/13/2013 | EP2566489A1 Dosage unit formulations of autologous dermal fibroblasts |
| 03/13/2013 | EP1392359B2 Specific binding proteins and uses thereof |
| 03/13/2013 | CN1934260B Method of producing negative strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter |
| 03/13/2013 | CN1721529B Trap vector and gene trapping method by using the same |
| 03/13/2013 | CN1606618B Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
| 03/13/2013 | CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/13/2013 | CN102971431A Process for producing sulfur-containing alpha-amino acid compound |
| 03/13/2013 | CN102971428A Plants having increased tolerance to herbicides |
| 03/13/2013 | CN102971421A Methods for generating endogenously tagged protein |
| 03/13/2013 | CN102971416A Methods and compositions for expanding and stabilizing natural regulatory T cells |
| 03/13/2013 | CN102971415A Platelet-derived growth factor-BB production promoter, and mesenchymal stem cell production promoter, stem cell stabilizer and dermis regenerator each comprising same |
| 03/13/2013 | CN102971414A Treatment of bone fracture |
| 03/13/2013 | CN102971411A Disposable set for cell culture, cell culture device and cell preparation method |
| 03/13/2013 | CN102971019A Methods for complex tissue engineering |
| 03/13/2013 | CN102970862A Combinations including Cry34ab/35ab and Cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 03/13/2013 | CN102965393A Method for preparing human induced pluripotent stem cells and use of human induced pluripotent stem cells |
| 03/13/2013 | CN102965392A Cultivation of sheath blight-resisting transgenic paddy rice and special vector |
| 03/13/2013 | CN102965357A N-acylhomoserine lactonase QsdA-RH5 with substrate specificity and coding gene and application thereof |
| 03/13/2013 | CN102965354A Phosphofructokinase and application of encoding genes thereof |
| 03/13/2013 | CN102965353A Maltose substrate specificity improved cyclodextrin glycosyltransferase and preparation method thereof |